Evidence map›Paper›PMID 39600710›Full record

ArticleFrontiers in immunology2024

Neutrophils enhance the clearance of systemic amyloid deposits in a murine amyloidoma model.

Trevor J Hancock, Marina Vlasyuk, James S Foster, Sallie Macy, Daniel C Wooliver, Manasi Balachandran, Angela D Williams, Emily B Martin, Stephen J Kennel, Eric R Heidel and 2 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Trevor J HancockDepartment of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.
Marina VlasyukDepartment of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.
James S FosterDepartment of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.
Sallie MacyDepartment of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.
Daniel C WooliverDepartment of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.
Manasi BalachandranDepartment of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.
Angela D WilliamsDepartment of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.
Emily B MartinDepartment of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.
Stephen J KennelDepartment of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.
Eric R HeidelDepartment of Surgery, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.
Jonathan S WallDepartment of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.
Joseph W JacksonDepartment of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Amyloid-specific antibodies have been shown to opsonize and enhance amyloid clearance in systemic amyloidosis mouse models. However, the immunological mechanisms by which amyloid is removed have not been clearly defined. Previous reports from preclinical Methods: Immunocompromised nude mice injected subcutaneously with patient-derived AL amyloid extract (generating a localized "amyloidoma") were used to circumvent confounding factors contributed by the adaptive immune system and served as the model system. Two representative AL amyloid extracts were used, ALλ(CLA), which is refractory to clearance, and ALκ(TAL), which is readily cleared in mice. Neutrophil recruitment to the amyloid masses, cellular activation, and propensity to engulf amyloid were assessed. Results: Immunophenotyping of amyloidomas from animals implanted with 2 mg of either ALλ or ALκ revealed that more neutrophils were recruited to ALκ amyloid masses as compared to the ALλ material, which was generally devoid of neutrophils. Discussion: Neutrophils may not directly mediate amyloid clearance through phagocytosis; however, these cells can be stimulated by the amyloid and may function to facilitate phagocytosis and amyloid clearance by professional phagocytes (

Indexed as

Disease Models, AnimalNeutrophilsPhagocytosisAmyloidAmyloidosisAnimalsHumansMiceMice, NudeNeutrophil InfiltrationPlaque, AmyloidAmyloidAL amyloidosisamyloid phagocytosisamyloid resolutionneutrophil NETsneutrophils in amyloid

Identifiers

PMID39600710
PMCPMC11588727

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.